Restatement of Previously Issued Financial Statements (Tables)

12 Months Ended

Dec. 31, 2021

Condensed Financial Information Disclosure [Abstract]

Schedule of reclassification of all public shares to temporary equity

	As
	Previously									As Since
	Reported			Adjustments #1			Adjustments #2			The Restated
Balance sheet as of December 31, 2020
Warrant liabilities	$	-		$	390,000		$	-		$	390,000
Deferred underwriting compensation		1,025,948			-			814,052			1,840,000
Total liabilities		3,230,972			390,000			814,052			4,435,024
Ordinary shares subject to possible redemption		40,723,074			(390,000	)		5,666,926			46,000,000
Ordinary shares		2,093			37			(755	)		1,375
Additional paid-in capital		4,990,205			(160,037	)		(4,830,168	)		-
Retained earnings (accumulated deficit)	$	(2,470	)	$	160,000		$	(1,650,055	)	$	(1,492,525	)

	As
	Previously									As
	Reported			Adjustments #1			Adjustments #2			Restated
Statement of operations for the year ended December 31, 2020
Change in fair value of warrant liabilities		-			130,000			-			130,000
Net (loss) income		(167,426	)		130,000			-			(37,426	)
Basic and diluted weighted average shares outstanding, ordinary share subject to possible redemption					-			4,600,000			4,600,000
Basic and diluted net loss per share, ordinary share subject to possible redemption					-			(0.01	)		(0.01	)
Basic and diluted weighted average shares outstanding, non-redeemable ordinary shares		2,092,586			(74,586	)		(643,000	)		1,375,000
Basic and diluted net (loss) income per share, non-redeemable ordinary shares	$	(0.22	)	$	0.06		$	0.15		$	(0.01	)

	As
	Previously								As
	Reported			Adjustments #1		Adjustments #2			Restated
Statement of cash flows for the year ended December 31, 2020
Change in fair value of warrant liabilities		-			130,000		-			130,000
Net (loss) income		(167,426	)		130,000		-			(37,426	)
Change in value of shares subject to redemption		255,356			-		(255,356	)		-
Statement of changes in shareholders’ deficit for the year ended December 31, 2020
Ordinary shares subject to possible redemption – ordinary shares – no. of shares		162,322			-		(162,322	)		-
Ordinary shares subject to possible redemption – ordinary shares – amount		163			-		(163	)		-
Ordinary shares subject to possible redemption– additional paid-in capital		255,193			-		(255,193	)		-
Ordinary shares subject to possible redemption – total shareholder’s equity		255,356			-		(255,356	)		-
Net income (loss) – accumulated deficit		(167,426	)		130,000		-			(37,426	)
Net income (loss) – total shareholder’s deficit	$	(167,426	)	$	130,000	$	-		$	(37,426	)